PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cellular and Molecular Research Center, Sabzevar University of Medical Science, Sabzevar, Iran.\', \'Department of Clinical Biochemistry, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.\', \'Medical Physics Department, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.\', \'Department of Microbiology and Virology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.\', \'Department of Medical Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.\', \'Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2174/1389201021666201009154517
?:hasPublicationType
?:journal
  • Current pharmaceutical biotechnology
is ?:pmid of
?:pmid
?:pmid
  • 33038909
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.574
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Targeted Delivery of CRISPR/Cas13 as a Promising Therapeutic Approach to Treat SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all